Comparing robotic and video game therapy for improving hand function in stroke patients
Comparison of Tenascin-C Value Rates and Functional Outcomes Between Exergame Therapy and Robotic Therapy in Post-Stroke Patients
This study is testing whether robotic therapy, video game therapy, or standard rehab helps stroke patients improve their hand function better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Sex | All |
| Sponsor | Hasanuddin University Academic / other |
| Locations | 2 sites (Makassar, South Sulawesi and 1 other locations) |
| Trial ID | NCT06563206 on ClinicalTrials.gov |
What this trial studies
This clinical trial compares the effectiveness of robotic therapy, exergame therapy, and standard rehabilitation in improving hand function among post-stroke patients. Participants will be randomly assigned to one of three groups: robotic therapy, exergame therapy, or standard rehabilitation. The study will assess functional outcomes and levels of Tenascin-C over a six-week period, with follow-up measurements taken before and after the intervention. The aim is to determine which therapy provides the best recovery outcomes for stroke patients.
Who should consider this trial
Good fit: Ideal candidates for this study are post-stroke patients who have stable hemodynamics and neurological states and have not previously undergone any rehabilitation interventions.
Not a fit: Patients with severe cognitive disorders, significant sensory deficits, or other uncontrolled medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies for stroke patients, enhancing their recovery of hand function.
How similar studies have performed: Other studies have shown promising results with robotic and video-assisted rehabilitation approaches, suggesting potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients after ischemic or hemorrhagic stroke * stable hemodynamics and neurologic state. * Patients have never undergone treatment with any intervention * Able to watch television with or without glasses from a distance of 1 meter. * Patients can understand informed consent to participate in research Exclusion Criteria: * Patients with a history of seizures or epilepsy. * Patients with severe cognitive disorders that can interfere with research objectives (MMSE score \<24). * Patients with field deficits or severe vision disorders. * The patient is unable to sit upright without help. * Patients with significant pain in the affected upper limb. * Patients with significant sensory decreases in the upper limb that are affected * Patients with other medical conditions (musculoskeletal, neuromuscular, cardio respiration) are uncontrolled and are at risk of disrupting the ability to exercise. Dropout Criteria * Patients who were declared dead * Refusing to continue the training session or less \< 50% of all sessions. * Experiencing hemodynamic and neurological disorders during the training program process. * Experiencing cybersickness twice in successive training sessions
Where this trial is running
Makassar, South Sulawesi and 1 other locations
- Hasanuddin University, Faculty of Medicine — Makassar, South Sulawesi, Indonesia (Recruiting)
- Wahidin Sudirohusodo General Hospital — Makassar, South Sulawesi, Indonesia (Recruiting)
Study contacts
- Principal investigator: Rumaisah Hasan, MD — Hasanuddin University
- Study coordinator: Auliyah Fadly, MD
- Email: muh.auliyah.fadly@gmail.com
- Phone: +6281234328649
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.